Form 4: Precision BioSciences Director Melinda Brown Acquires Additional Shares
SEC Form 4 Filing
Director Melinda Brown purchased 1,839 shares of Precision BioSciences (DTIL) at $4.75 per share on March 26, 2025, increasing her direct holdings.
Summary
- On March 26, 2025, Melinda Brown, a director of Precision BioSciences Inc. (DTIL), acquired 1,839 shares of common stock at a price of $4.75 per share.
- The transaction increased Brown's direct ownership to 9,057 shares.
- The transaction was reported on a Form 4 filing with the SEC on March 28, 2025.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares is generally a good sign, but the purchase is relatively small and may not be highly significant.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. This purchase by a director could be interpreted as a positive signal.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/26/2025 | Date of transaction: Melinda Brown purchased shares of DTIL. |
| 03/28/2025 | Date of Form 4 filing with the SEC. |
Keywords
Precision BioSciences, DTIL, Melinda Brown, Director, Stock Acquisition, Form 4, SEC Filing, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.